This inventor holds 44 USPTO granted patents and 9 published patent applications, plus 4 CIPO patents and 11 EPO patents, primarily in Fatty Acid Amide Hydrolase. Top assignees: Infinity Pharmaceuticals, Inc., Infinity Discovery, Inc., Surface Logix, Inc.. Active years: 2010-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Arlington, MA (US) (2010)
- Winchester, MA (US) (2010 - 2023)
Company Filing History:
33 out of 108 
9 out of 12 
1 out of 42 
Years Active: 2010-2023
Areas of Expertise:
Title: The Innovative Contributions of Michael J. Grogan
Introduction: Michael J. Grogan, a prolific inventor based in Winchester, MA, holds an impressive portfolio of 44 patents to his name. His work primarily focuses on advancements in the field of medicinal chemistry, particularly involving cyclopamine analogs, which have significant implications for treating various health conditions.
Latest Patents: Among his latest innovations are the patents related to "Methods of Use of Cyclopamine Analogs" and "Cyclopamine Analogs." These inventions delineate methods for treating various conditions using derivatives of cyclopamine, showcasing Grogan's commitment to enhancing therapeutic options through chemical innovation.
Career Highlights: Throughout his career, Michael has made notable contributions while working with companies such as Infinity Pharmaceuticals, Inc. and Infinity Discovery, Inc. His expertise in drug development and medicinal chemistry has played a pivotal role in advancing research within these organizations.
Collaborations: Grogan's collaborative efforts are evident through his work alongside distinguished peers like Alfredo C. Castro and Martin R. Tremblay. These partnerships exemplify how teamwork can drive innovation and lead to groundbreaking discoveries in the pharmaceutical field.
Conclusion: Michael J. Grogan's extensive experience and innovative spirit have firmly established him as a valuable contributor to the world of medicinal advancements. With a portfolio that continues to grow, his work promises to impact various therapeutic areas, ensuring a healthier future for many.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile